Next Article in Journal
Comment on Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. Cancers 2021, 13, 1176
Next Article in Special Issue
Oligometastatic Disease Detection with 68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact
Previous Article in Journal
D-Propranolol Impairs EGFR Trafficking and Destabilizes Mutant p53 Counteracting AKT Signaling and Tumor Malignancy
Previous Article in Special Issue
Oligometastatic Cancer: Key Concepts and Research Opportunities for 2021 and Beyond
 
 
Systematic Review

Article Versions Notes

Cancers 2021, 13(14), 3623; https://doi.org/10.3390/cancers13143623
Action Date Notes Link
article xml file uploaded 20 July 2021 07:30 CEST Original file -
article xml uploaded. 20 July 2021 07:30 CEST Update -
article pdf uploaded. 20 July 2021 07:30 CEST Version of Record -
article supplementary file uploaded. 20 July 2021 07:30 CEST - https://www.mdpi.com/2072-6694/13/14/3623#supplementary
article html file updated 20 July 2021 07:31 CEST Original file -
article xml file uploaded 23 July 2021 05:57 CEST Update -
article xml uploaded. 23 July 2021 05:57 CEST Update -
article pdf uploaded. 23 July 2021 05:57 CEST Updated version of record -
article html file updated 23 July 2021 05:59 CEST Update -
article xml file uploaded 23 July 2021 06:23 CEST Update -
article xml uploaded. 23 July 2021 06:23 CEST Update https://www.mdpi.com/2072-6694/13/14/3623/xml
article pdf uploaded. 23 July 2021 06:23 CEST Updated version of record https://www.mdpi.com/2072-6694/13/14/3623/pdf
article html file updated 23 July 2021 06:24 CEST Update -
article html file updated 27 July 2022 05:35 CEST Update https://www.mdpi.com/2072-6694/13/14/3623/html
Back to TopTop